Stay updated with breaking news from Nasdaq Glpg. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Galapagos NV (NASDAQ:GLPG – Get Rating)’s share price passed below its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $41.34 and traded as low as $37.43. Galapagos shares last traded at $37.46, with a volume of 193,386 shares trading hands. Analyst Upgrades and Downgrades A number of […]
Equities analysts expect Galapagos NV (NASDAQ:GLPG – Get Rating) to post sales of $97.35 million for the current fiscal quarter, according to Zacks Investment Research. Two analysts have issued estimates for Galapagos’ earnings. The lowest sales estimate is $58.80 million and the highest is $135.89 million. Galapagos posted sales of $184.41 million during the same […]
Brokerages expect Galapagos NV (NASDAQ:GLPG – Get Rating) to announce ($0.79) earnings per share (EPS) for the current fiscal quarter, according to Zacks Investment Research. Two analysts have issued estimates for Galapagos’ earnings, with estimates ranging from ($1.62) to $0.05. Galapagos reported earnings of ($1.18) per share in the same quarter last year, which suggests […]
Galapagos (NASDAQ:GLPG – Get Rating) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a research note issued on Wednesday, Zacks.com reports. The brokerage currently has a $63.00 price target on the biotechnology company’s stock. Zacks Investment Research‘s target price indicates a potential upside of 9.13% from the stock’s […]
Galapagos (NASDAQ:GLPG – Get Rating) and Pacira BioSciences (NASDAQ:PCRX – Get Rating) are both mid-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, earnings, analyst recommendations, dividends, risk, profitability and institutional ownership. Profitability This table compares Galapagos and Pacira BioSciences’ net margins, […]